Industries > Pharma > Global Spine Biologics Market Forecast 2016-2026

Global Spine Biologics Market Forecast 2016-2026

Demineralized Bone Matrix, BMP/Growth Factor, Bone Substitutes, Cell Based Matrices, Machined Bone, Allograft Bone, Platelet Concentrators, Traditional Fusion, Interbody Fusion, Inpatient and Outpatient Surgery Centers

PUBLISHED: 25 November 2016
PAGES: 142
PRODUCT CODE: PHA0153
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
SKU: PHA0153 Categories: ,

The global Spine Biologics market is expected to grow at a moderate single digit growth rate over the forecast period. The global spine biologics market was valued at $2,997m in 2015. Visiongain forecasts this market to increase to $3,899m in 2020. The market will then continue to increase to $5,604m in 2026, growing at a CAGR 6.2% between 2020 and 2026.

How this report will benefit you:
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new report you find 142-page report you will receive 125 in-Depth charts – all unavailable elsewhere.

The 142 page report provides clear detailed insight into the global spine biologics market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope
Global Spine Biologics market forecasts from 2016-2026

• Spine biologics national market forecasts from 2016-2026, covering:
– United States
– Canada
– Germany
– France
– United Kingdom
– Italy
– Spain
– Russia
– Rest of Europe
– Japan
– China
– India
– Australia
– Rest of Asia-Pacific
– Rest of the World

Global Spine Biologics Market Forecast 2016-2026

• Spine Biologics submarket forecasts from 2016-2026 covering:

– Revenue forecasts to 2026 are provided for the following segments in the spine biologics market, by product:
• Demineralized Bone Matrix
• BMP/Growth Factor
• Bone Substitutes
• Cell Based Matrices
• Machined Bone
• Allograft Bone
• Platelet Concentrators

– Revenue forecasts to 2026 are provided for the following segments in the spine biologics market, by type of surgery:
• Traditional Fusion
• Interbody Fusion

– Revenue forecasts to 2026 are provided for the following segments in the spine biologics market, by end user:
• Inpatient Surgery Centers
• Outpatient Surgery Centers

• Analysis of the key factors driving growth in the global, regional and country level of spine biologics market from 2016-2026

• Assesses selected leading companies, examining recent performance and outlooks.

• Assessment of leading companies in the spine biologics market as well as strengths, weaknesses, opportunities, and threats in the market.

Visiongain’s study is intended for anyone requiring commercial analyses for the Spine Biologics Market and leading companies. You find data, trends and predictions.

Buy our report today Global Spine Biologics Market Forecast 2016-2026: Demineralized Bone Matrix, BMP/Growth Factor, Bone Substitutes, Cell Based Matrices, Machined Bone, Allograft Bone, Platelet Concentrators, Traditional Fusion, Interbody Fusion, Inpatient and Outpatient Surgery Centers.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Spine Biologics Market Forecast 2016-2026


Download sample pages

Complete the form below to download your free sample pages for Global Spine Biologics Market Forecast 2016-2026


Latest Pharma news

Visiongain Publishes Cell-Based Assays Market Report to 2030

Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.

09 April 2021

READ

Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031

The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

06 April 2021

READ

Visiongain Publishes Artificial Intelligence (AI) in Drug Discovery Market Report 2021-2031

Factors such as increasing data volumes for analysis, quick turnaround time for the discovery and development new drug, computing power, AI also helps in targeted manufacturing and others drive the market growth.

01 April 2021

READ

Visiongain Publishes Inhalation & Nasal Spray Generic Drugs Market Report 2021-2031

Rising prevalence of chronic respiratory diseases including asthma, COPD, and allergic rhinitis; rising geriatric population, escalating investment in drug R&D by biopharmaceutical & pharmaceutical companies; growing respiratory health care awareness; and new product launches worldwide are some of the major factors that boosting the growth of global inhalation & nasal spray generic drugs market.

31 March 2021

READ

Categories